Suppr超能文献

瑞典儿科人群中报告的 10 年间药物不良反应。

Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.

机构信息

Clinical Pharmacology, Institute of Medicine, the Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

出版信息

Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):79-86. doi: 10.1002/pds.2265. Epub 2011 Nov 10.

Abstract

PURPOSE

Psychiatric Adverse Drug Reactions (ADRs) are frequent in the pediatric population. The aim of the present study was to analyze spontaneously reported psychiatric ADRs in children during a 10-year period.

METHODS

All spontaneously reported Individual Case Safety Reports (ICSRs) concerning children (<18 years old) and psychiatric adverse reactions assessed as at least possible, registered in the Swedish Drug Information System (SWEDIS) during the period 2001-2010, were extracted and characterized. Age and sex distribution and labeling/registration status were studied.

RESULTS

A total of 600 ICSRs concerning 744 psychiatric adverse reactions were identified and included in the analysis. Boys were overrepresented among included ICSRs (60.3% vs. 39.7%; p < .001). After exclusion of vaccines, the three most frequently suspected drugs were montelukast, centrally working sympathomimetic drugs, and inhaled glucocorticoids. Serious adverse reactions were reported more frequently for drugs used off-label than for drugs used according to the Swedish Physician's Desk Reference. Aggressiveness was reported more frequently for boys than for girls as were suicidal conditions.

CONCLUSIONS

Psychiatric ADRs in the pediatric population have been reported for a wide range of reactions and drugs and display age and sex differences including a higher number of suicidal reactions in boys. An association was seen between serious reactions and off-label drug use. Further studies are needed to elucidate safety aspects of unlicensed drugs and drugs used off-label and whether there are differences in children's susceptibility to develop ADRs.

摘要

目的

精神科药物不良反应(ADR)在儿科人群中很常见。本研究旨在分析 10 年间儿童自发报告的精神科 ADR。

方法

提取并分析了 2001 年至 2010 年期间在瑞典药物信息系统(SWEDIS)中登记的,与儿童(<18 岁)和至少可能被评估为精神科不良反应的自发报告的个别病例安全性报告(ICSR)。研究了年龄和性别分布以及标签/登记状况。

结果

共确定了 600 份涉及 744 例精神科不良反应的 ICSR,并纳入了分析。包括的 ICSR 中男孩比例过高(60.3%对 39.7%;p<.001)。排除疫苗后,最常怀疑的三种药物是孟鲁司特、中枢作用拟交感神经药物和吸入性糖皮质激素。标签外用药比瑞典医师用药参考手册中规定的用药报告的严重不良反应更频繁。攻击性在男孩中比女孩更常见,自杀情况也是如此。

结论

儿科人群的精神科 ADR 已报告有多种反应和药物,且存在年龄和性别差异,包括男孩出现更多的自杀反应。严重反应与标签外用药之间存在关联。需要进一步研究未批准药物和标签外用药的安全性方面,以及儿童对不良反应的易感性是否存在差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验